4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000219
Director sold 28,000 shares at $60.00 ($1,680,000)
- Director acquired 28,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
KLEIN JOSEPH III · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +16,000 | 16,000 | I | ||
| 2025-09-03 | Exercise or conversion : show line 2 in the form 10b5-1 | +12,000 | 28,000 | I | ||
| 2025-09-03 | Sale : show line 3 in the form 10b5-1 | −28,000 | $60.00 | $1,680,000 | 0 | I |
| Open-market sales · 28,000 sh · avg $60.00 · $1,680,000 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-03 | Exercise or conversion : show line 4 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −12,000 | 0 | I |
| 2025-09-03 | Exercise or conversion : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −16,000 | 0 | I |
Loading xslF345X05/edgardoc.xml…